Prescriptions for GLP-1 receptor agonists have skyrocketed since ... Among the groups, body mass index (BMI), HbA1c levels, healthcare utilization rates, and hypertensive disease rates were ...

However, the impact of combining GLP-1 RA therapy with FreeStyle Libre systems (FSL) has not been previously explored. To ...

Novo Nordisk's GLP-1 agonist Ozempic (semaglutide ... was the change from baseline at 24 weeks in glycated haemoglobin (HbA1c) levels, a biomarker for blood glucose control.

SAN ANTONIO -- Research presented at the ObesityWeek annual meeting included studies on rationing of prescription medications ...

Semaglutide offers a multifaceted approach to type 2 diabetes treatment, enhancing insulin release and reducing blood sugar ...

Tirzepatide shows promise in reducing weight and preventing diabetes progression in people with obesity and prediabetes, with ...

Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie ...

Novo Nordisk's stock has dropped to $110 per share, but operational performance remains strong. See why I believe we are at ...

Q3 2024 Earnings Call Transcript November 14, 2024 Operator: Good afternoon, and welcome to Fractyl Health’s Third Quarter Financial Results and Business Updates Call. As a reminder, this conference ...

A new guideline released on World Diabetes Day will give GPs and other health professionals positive recommendations for optimal diabetes management ...